血清CA15-3、CEA及全身骨显像联合检查对乳腺癌骨转移的诊断价值

袁超; 陶健; 袁媛; 孙伟莉

doi:10.3760/cma.j.issn.1673-4114.2009.06.011

袁超 , 陶健 , 袁媛 , 孙伟莉

文章导航 > 国际放射医学核医学杂志 > 2009, 33 > 6: (353-355)

引用本文:

Citation:

血清CA15-3、CEA及全身骨显像联合检查对乳腺癌骨转移的诊断价值

蚌埠医学院第一附属医院核医学科, 蚌埠 233004

The diagnostic significance of CA15-3, CEA combined with whole body bone scan for bone metastases in patients with breast cancer

Department of Nuclear Medicine, the First Affiliated Hospital of Bengbu Medical College, Anhui Bengbu 233004, China

摘要: 目的探讨血清糖类抗原15-3(carbonhydrate antigen 15-3,CA15-3)、癌胚抗原(carcinoembryonic antigen,CEA)测定联合全身骨显像(WBS)对提高乳腺癌骨转移诊断的临床价值。方法对92例乳腺癌患者分别进行血清CA15-3、CEA检测和WBS,并进行对比分析。结果乳腺癌骨转移组,血清CA15-3和CEA水平显着增高,与无骨转移的乳腺癌组比较有统计学差异(CA15.3:t=91.8342;CEA:t=77.6323,P<0.01)。CA15-3、CEA及全身骨显像联合检测对诊断乳腺癌骨转移其灵敏度、特异度分别为95.74%、88.89%,较单独检测某项指标诊断效率均有提高。结论血清CA15-3、CEA及全身骨显像联合检测可提高乳腺癌骨转移的诊断效率,特别是全身骨显像结果模棱两可时意义更大。
- 乳腺肿瘤 /
- 肿瘤转移 /
- 全身成像 /
- 99m锝美罗酸盐 /
- 抗原,肿瘤相关,碳水化合物 /
- 癌胚抗原
Abstract: Objective To investigate the diagnostic significance of carbonhydrate anitigen 15-3,(CAl5-3), carcinoembryonic antigen(CEA) combined with whole body bone scan(WBS) for bone metastases in patients with breast cancer. Methods Serum levels of CA153 and CEA were measured and WBS was performed in 92 breast cancer patients. Results Serum levels of CA153 and CEA were higher in bone metastases group than in without bone metastases group significantly(CA15.3:t=91.8342; CEA:t=77.6323,P<0.01). The sensitivity and specificity of combined determinations of CA153, CEA and WBS were 95.74% and 88.89% respectively, its diagnostic efficiency was higher than any one of them. Conclusion The combined detection of CA153, CEA and WBS can improve the diagnostic efficiency of bone metastases in patient with breast cancer, especially when the results of bone scanning is equivocal.
- Breast neoplasms /
- Neoplasm metastasis /
- whole body imaging /
- Technetium Tc 99m medronate /
- Antigens,tumor-associated,carbohydrate /
- Carcinoembryonic antigen
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Araujo J,Logothetis C.Targeting Src signaling in metastatic bone disease.Int J Cancer,2009,124(1):1-6.
[2]	Wojtacki J,Kruszewski WJ,Sliwińska M,et al.Elevation of serum Ca 15-3 antigen:an early indicator of distant metastasis from breast cancer.Retrospective analysis of 733 cases.Przegl Lek,2001,58(6):498-503.
[3]	陆云飞,向俾庭,曾健,等.血清TSGF、CA153、CA125及CEA联合检测对乳腺癌的诊断价值.广西医科大学学报,2006,23(2):173-175.
[4]	Tubiana-Hulin M.Incidence,prevalence and distribution of bone metastasis.Bone,1991,12(suppl 1):S9-S10.
[5]	Harris L,Fritsche H,Mennel R,et al.American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.J Clin Oncol,2007,25(33):5287-5312.
[6]	Nicolini A,Carpi A,Ferrari P,et al.Utility of a serum tumourmarker pane] in the post-operative follow-up of breast cancerpatients with equivocal conventional radiological examinations.Tumour Biol,2003,24(6):275-280.
[7]	Zissimopoulos A,Petrakis G,Stellos K,et al.Procollagen-I,collagen telopeptide I,CEA,CA15-3 as compared to bone scintigraphy in patients with breast cancer-Hell J Nucl Med,2006,9(1):60-64.

[1]	路宝士 , 高玉芳 . 血清CA15-3、CEA检测联合全身骨显像在乳腺癌骨转移中的诊断价值. 国际放射医学核医学杂志, 2011, 35(2): 107-110. doi: 10.3760/cma.j.issn.1673-4114.2011.02.010
[2]	陶欣慰 , 黄钢 . ¹⁸F-FDGPET与⁹⁹Tc^m-MDP骨显像在诊断肿瘤骨转移中的比较. 国际放射医学核医学杂志, 2010, 34(6): 352-355. doi: 10.3760/cma.j.issn.1673-4114,2010.06.008
[3]	陶欣慰 , 黄钢 . F-FDGPET与 ⁹⁹Tc^m-MDP骨显像在诊断肿瘤骨转移中的比较. 国际放射医学核医学杂志, 2010, 34(6): 352-355. doi: 10.3760/cma.j.issn.1673-4114.2010.06.008
[4]	徐海青 , 段俊 , 吴边 . 全身骨显像诊断前列腺癌骨转移与PSA水平及病理分级的相关性研究. 国际放射医学核医学杂志, 2011, 35(1): 34-37. doi: 10.3760/cma.j.issn.1673-4114.2011.01.010
[5]	段云 , 杨颖卓 , 王乔 , 杨雯 , 何文果 , 徐蓉生 . SPECT/CT融合显像在肿瘤患者骨盆病变中的诊断价值. 国际放射医学核医学杂志, 2021, 45(5): 276-283. doi: 10.3760/cma.j.cn121381-202003044-00044
[6]	刘超 , 邓智勇 , 刘鹏杰 , 贾莉 . ⁸⁹SrCL₂与唑来膦酸联合治疗乳腺癌转移性骨肿瘤的疗效分析. 国际放射医学核医学杂志, 2014, 38(5): 300-303. doi: 10.3760/cma.j.issn.1673-4114.2014.05.006
[7]	刘道佳 , 唐明灯 , 林端瑜 , 倪雷春 , 林小敏 . ⁹⁹Tc^m-MDP全身骨显像、⁹⁹Tc^m-MDP SPECT-CT和¹⁸F-FDG SPECT-CT探测脊柱转移瘤的比较. 国际放射医学核医学杂志, 2011, 35(2): 89-92. doi: 10.3760/cma.j.issn.1673-4114.2011.02.006
[8]	叶慧 , 莫逸 , 谢爱民 , 彭翔 . ¹⁸F-氟脱氧葡萄糖PET-CT与99nTc-亚甲基二膦酸盐骨显像诊断转移性骨肿瘤的对比研究. 国际放射医学核医学杂志, 2008, 32(3): 147-150.
[9]	黄娟 , 颜剑豪 , 梁联保 , 江桂华 . 注射钆剂后弥散加权成像对乳腺肿瘤诊断的影响. 国际放射医学核医学杂志, 2015, 39(4): 287-291. doi: 10.3760/cma.j.issn.1673-4114.2015.04.003
[10]	卢婷婷 , 王雪 , 王晓慧 , 霍宗伟 , 杨国仁 . 胸部肿瘤放疗后椎体对⁹⁹Tc^m-MDP的摄取表现及分析. 国际放射医学核医学杂志, 2020, 44(4): 205-211. doi: 10.3760/cma.j.cn121381-201902031-00017

点击查看大图

计量

文章访问数: 1833
HTML全文浏览量: 227
PDF下载量: 2

血清CA15-3、CEA及全身骨显像联合检查对乳腺癌骨转移的诊断价值

蚌埠医学院第一附属医院核医学科, 蚌埠 233004

收稿日期: 2009-07-20

关键词:

摘要: 目的探讨血清糖类抗原15-3(carbonhydrate antigen 15-3,CA15-3)、癌胚抗原(carcinoembryonic antigen,CEA)测定联合全身骨显像(WBS)对提高乳腺癌骨转移诊断的临床价值。方法对92例乳腺癌患者分别进行血清CA15-3、CEA检测和WBS,并进行对比分析。结果乳腺癌骨转移组,血清CA15-3和CEA水平显着增高,与无骨转移的乳腺癌组比较有统计学差异(CA15.3:t=91.8342;CEA:t=77.6323,P<0.01)。CA15-3、CEA及全身骨显像联合检测对诊断乳腺癌骨转移其灵敏度、特异度分别为95.74%、88.89%,较单独检测某项指标诊断效率均有提高。结论血清CA15-3、CEA及全身骨显像联合检测可提高乳腺癌骨转移的诊断效率,特别是全身骨显像结果模棱两可时意义更大。